Thyrotropinomas

Endocrinology and Metabolism Clinics of North America

Volumn 37, Issue 1, 2008, Pages 123-134

  Beck Peccoz, Paolo ^a   Persani, Luca ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; DOPAMINE RECEPTOR; FOLLITROPIN; GROWTH HORMONE; LIOTHYRONINE; OCTREOTIDE; PROPRANOLOL; PROPYLTHIOURACIL; SEX HORMONE BINDING GLOBULIN; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; THIAMAZOLE; THYROTROPIN; THYROXINE;

ALPHA CHAIN; CHOLELITHIASIS; CLINICAL EXAMINATION; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; GLUCOSE INTOLERANCE; HUMAN; HYPERTHYROIDISM; HYPOPHYSECTOMY; HYPOTHYROIDISM; PATHOPHYSIOLOGY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REVIEW; THYROTROPIN SECRETING ADENOMA;

DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERTHYROIDISM; PITUITARY NEOPLASMS; THYROXINE; TRIIODOTHYRONINE;

EID: 38349156151     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2007.10.001     Document Type: Review

References (36)

1. Beck-Peccoz P., Brucker-Davis F., Persani L., et al. Thyrotropin-secreting pituitary tumors. Endocr Rev 17 (1996) 610-638
2. Beck-Peccoz P, Persani L. Thyrotropin-secreting pituitary adenomas. In: Thyroid disease manager. Available at: http://www.thyroidmanager.org/.
3. Greenman Y., and Melemd S. Thyrotropin-secreting pituitary tumors. In: Melmed S. (Ed). The pituitary. 2nd edition (2002), Blackwell Publishing, London 561-574
4. Terzolo M., Orlandi F., Bassetti M., et al. Hyperthyroidism due to a pituitary adenoma composed of two different cell types, one secreting alpha-subunit alone and another cosecreting alpha-subunit and thyrotropin. J Clin Endocrinol Metab 72 (1991) 415-421
5. Socin H.V., Chanson P., Delemer B., et al. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 148 (2003) 433-442
6. Refetoff S., Weiss R.E., and Usala S.J. The syndromes of resistance to thyroid hormone. Endocr Rev 14 (1993) 348-399
7. Melmed S. Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest 112 (2003) 1603-1618
8. Dong Q., Brucker-Davis F., Weintraub B.D., et al. Screening of candidate oncogenes in human thyrotroph tumors: absence of activating mutations of the Gaq, Ga11, Gas, or thyrotropin-releasing hormone receptor genes. J Clin Endocrinol Metab 81 (1996) 1134-1140
9. Asteria C., Anagni M., Persani L., et al. Loss of heterozigosity of the MEN1 gene in a large series of TSH-secreting pituitary adenomas. J Endocrinol Invest 24 (2001) 796-801
10. Taylor T.J., Donlon S.S., Bale A.E., et al. Treatment of a thyrotropinoma with octreotide-LAR in a patient with multiple endocrine neoplasia-1. Thyroid 10 (2000) 1001-1007
11. Ando S., Sarlis N.J., Oldfield E.H., et al. Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor. J Clin Endocrinol Metab 86 (2001) 5572-5576
12. Ando S., Sarlis N.J., Krishnan J., et al. Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol Endocrinol 15 (2001) 1529-1538
13. Filopanti M., Ballare E., Lania A.G., et al. Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas. J Endocrinol Invest 27 (2004) 937-942
14. Ezzat S., Horvath E., Kovacs K., et al. Basic fibroblast growth factor expression by two prolactin and thyrotropin-producing pituitary adenomas. Endocr Pathol 6 (1995) 125-134
15. Webster J., Peters J.R., Smith J., et al. Pituitary stone: two cases of densely calcified thyrotrophin-secreting pituitary adenomas. Clin Endocrinol (Oxf) 40 (1994) 137-143
16. Brucker-Davis F., Oldfield E.H., Skarulis M.C., et al. Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84 (1999) 476-486
17. Brown R.L., Muzzafar T., Wollman R., et al. A pituitary carcinoma secreting TSH and prolactin: a non-secreting adenoma gone awry. Eur J Endocrinol 154 (2006) 639-643
18. Persani L., Preziati D., Matthews C.H., et al. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH. Clin Endocrinol (Oxf) 47 (1997) 207-214
19. Bertherat J., Brue T., Enjalbert A., et al. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. J Clin Endocrinol Metab 75 (1992) 540-546
20. Gancel A., Vuillermet P., Legrand A., et al. Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas. Clin Endocrinol 40 (1994) 421-428
21. Chanson P., Weintraub B.D., and Harris A.G. Octreotide therapy for thyroid stimulating-secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med 119 (1993) 236-240
22. Kuhn J.M., Arlot S., Lefebvre H., et al. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. J Clin Endocrinol Metab 85 (2000) 1487-1491
23. Kienitz T., Quinkler M., Strasburger C.J., et al. Long-term management in five cases of TSH-secreting pituitary adenomas: a single center study and review of the literature. Eur J Endocrinol 157 (2007) 39-46
24. Horiguchi K., Yamada M., Umezawa R., et al. Somatostatin receptor subtypes mRNA in TSH-secreting pituitary adenomas: a case showing a dramatic reduction in tumor size during short octreotide treatment. Endocr J 54 (2007) 371-378
25. Yoshihara A., Isozaki O., Hizuka N., et al. Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: a possible marker for predicting long-term response to octreotide therapy. Endocr J 54 (2007) 133-138
26. Mannavola D., Persani L., Vannucchi G., et al. Different response to chronic somatostatin analogues in patients with central hyperthyroidism. Clin Endocrinol (Oxf) 62 (2005) 176-181
27. Losa M., Magnani P., Mortini P., et al. Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: correlation with the effect of a single administration of octreotide on serum TSH levels. Eur J Nucl Med 24 (1997) 728-731
28. Cooper D.S., and Wenig B.M. Hyperthyroidism caused by an ectopic TSH-secreting pituitary tumor. Thyroid 6 (1996) 337-342
29. Pasquini E., Faustini-Fustini M., Sciarretta V., et al. Ectopic TSH-secreting pituitary adenoma of the vomerosphenoidal junction. Eur J Endocrinol 148 (2003) 253-257
30. Hall W.A., Luciano M.G., Doppman J.L., et al. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 120 (1994) 817-882
31. Watanabe K., Kameya T., Yamauchi A., et al. Thyrotropin-producing adenoma associated with pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 76 (1993) 1025-1031
32. Losa M., Giovanelli M., Persani L., et al. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 81 (1996) 3086-3090
33. Ohki M., Sato K., Tuchiya D., et al. [A case of TSH-secreting pituitary adenoma associated with an unruptured aneurysm: successful treatment by two-stage operation and gamma knife]. No To Shinkei 51 (1999) 895-899 [in Japanese]
34. Daousi C., Foy P.M., and MacFarlane I.A. Ablative thyroid treatment for thyrotoxicosis due to thyrotropin-producing pituitary tumours. J Neurol Neurosurg Psychiatry 78 (2007) 93-95
35. Rocheville M., Lange D.C., Kumar U., et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288 (2000) 154-157
36. Blackhurst G., Strachan M.W., Collie D., et al. The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy. Clin Endocrinol (Oxf) 57 (2002) 401-404